NCT05507619

Brief Summary

Knee osteoarthritis (KOA) is one of the largest and fast-growing causes of pain, impaired mobility, and poor quality of life in the elderly worldwide. Despite a significant increase in Traditional Chinese Medicine (TCM) utilisation, in particular acupuncture, as first or second-line treatment among local KOA patients, there exists a lack of high-quality evidence on its efficacy and local practice guidelines for TCM use in KOA tailored to our specific population demographic. HarmoKNEE trial aims to address these gaps by evaluating the short and medium-term clinical and cost-effectiveness of TCM acupuncture with far-infrared heat therapy in addition to standard care, compared to standard care alone. Through a robust process and economic evaluation, the investigators aim to inform evidence-based practice for KOA patients in Singapore to facilitate the large-scale implementation of a comprehensive and holistic model of care which harmonises elements from Western medicine and TCM. The investigators hypothesize that acupuncture with heat therapy as an adjunct to standard care is clinically more effective than standard care alone. This will be a multi-centre pragmatic, parallel-arm, single-blinded, effectiveness-implementation hybrid randomised control trial. KOA patients will be randomised to either the control arm (standard care only) or intervention arm (biweekly sessions of acupuncture with heat therapy over 6 weeks, in addition to standard care). A mixed-method approach through an embedded process evaluation will facilitate large scale implementation. An economic evaluation will be performed to evaluate financial sustainability

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
173

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2022

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 16, 2022

Completed
1 day until next milestone

Study Start

First participant enrolled

August 17, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 19, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2024

Completed
Last Updated

August 19, 2022

Status Verified

August 1, 2022

Enrollment Period

2 years

First QC Date

August 16, 2022

Last Update Submit

August 17, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Knee Osteoarthritis Outcome Score (KOOS-12)

    Derived from the original 42-item Knee injury and Osteoarthritis Outcome Score (KOOS), KOOS-12 reduces respondent burden by 70% from the original KOOS while providing scale scores for knee-specific Pain, Function and QOL, along with a summary measure of overall knee impact. The KOOS sub scales are scored using the method of summated ratings and transformed to range from 0 to 100, with 0 representing extreme knee problems and 100 representing no knee problem. The KOOS-12 Summary knee impact score is calculated as the average of the KOOS-12 Pain, KOOS-12 Function and KOOS-12 QOL scale scores. It also ranges from 0 to 100, where 0 is the worst possible and 100 is the best possible score.

    Baseline, Change from Baseline to 6 weeks, Change from Baseline to 3 months, Change from Baseline to 6 months

Secondary Outcomes (10)

  • Knee Injury and Osteoarthritis Outcomes Score (KOOS) subscales - Pain, Function, QoL

    Baseline, Change from Baseline to 6 weeks, Change from Baseline to 3 months, Change from Baseline to 6 months

  • EuroQol-5 Dimensions (EQ-5D-5L)

    Baseline, Change from Baseline to 6 weeks, Change from Baseline to 3 months, Change from Baseline to 6 months

  • Patient Health Questionnaire 4 (PHQ-4)

    Baseline, Change from Baseline to 6 weeks, Change from Baseline to 3 months, Change from Baseline to 6 months

  • Pain, Enjoyment, General Activity Scale (PEG)

    Baseline, Change from Baseline to 6 weeks, Change from Baseline to 3 months, Change from Baseline to 6 months

  • Functional Assessment - 30s chair stand test

    Baseline, Change from Baseline to 3 months, Change from Baseline to 6 months

  • +5 more secondary outcomes

Other Outcomes (7)

  • University of California, Los Angeles (UCLA) activity score

    Baseline, Change from Baseline to 6 weeks, Change from Baseline to 3 months, Change from Baseline to 6 months

  • Global perceived effect (GPE)

    Assess at 3 months, 6 months, 12 months

  • Patient Acceptable Symptom State (PASS)

    Assess at 3 months, 6 months, 12 months

  • +4 more other outcomes

Study Arms (2)

Control

ACTIVE COMPARATOR
Other: Standard Care

Intervention

EXPERIMENTAL
Other: Acupuncture with Heat Therapy + Standard Care

Interventions

Biweekly sessions of acupuncture with heat therapy over 6 weeks (total 12 sessions), in addition to standard care (e.g. physiotherapy, dietetics, pain management).

Intervention

Treatment as prescribed by orthopaedic surgeon routinely (e.g. physiotherapy, dietetics, pain management)

Control

Eligibility Criteria

Age45 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • to 99 years old
  • Independent Community Mobilizers with or without walking aids
  • Conversant in English or Chinese
  • NICE clinical criteria for OA knee

You may not qualify if:

  • Alternative diagnosis to KOA e.g., referred pain from the spine or hip
  • Other forms of arthritis eg., inflammatory, post-traumatic
  • Inability to comply with study protocol e.g., cognitive impairment
  • Previous knee arthroplasty
  • Wheelchair-bound patients
  • Medical conditions that will medically interfere with study involvement e.g., decompensated heart failure, stroke, end-stage renal failure
  • Allergies to metal (needles)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Singapore Chung Hwa Medical Institution

Singapore, Singapore

Location

Tan Tock Seng Hospital

Singapore, Singapore

Location

Related Publications (1)

  • Tan BY, Tan CY, Tan TL, Yang SY, Chew GLS, Tan SI, Chua YC, Yan YW, Soh DBQ, Goh TH, Ng PJ, Ng YT, Kuan SB, Teo BS, Kong KH, Pereira MJ, Ng HP. Heat and Acupuncture to Manage Osteoarthritis of the Knee (HARMOKnee): Protocol for an Effectiveness-Implementation Hybrid Randomized Controlled Trial. JMIR Res Protoc. 2024 Apr 3;13:e54352. doi: 10.2196/54352.

MeSH Terms

Conditions

Osteoarthritis, Knee

Interventions

Acupuncture TherapyDiathermyStandard of Care

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsHyperthermia, InducedQuality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Bryan Tan

    Woodlands Health

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Bryan Tan

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant

Study Record Dates

First Submitted

August 16, 2022

First Posted

August 19, 2022

Study Start

August 17, 2022

Primary Completion

July 31, 2024

Study Completion

July 31, 2024

Last Updated

August 19, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations